Screening 2

• FC 17-01 • Inter- and intra laboratory quality monitoring of HPV test-performance in the Dutch cervical cancer screening program See abstract > R. Rob SCHUURMAN • FC 17-02 • P16/KI67 double staining for triage positive results in primary cervical cancer screening based on DNA HPV testing See abstract > M. M. TRZESZCZ • FC 17-03 • HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test See abstract > N. N.J. POLMAN • FC 17-04 • Non-inferiority of Onclarity HPV genotyping compared with HC2 in a German HPV-screening pilot project (WOLPHSCREEN) See abstract > A. A. DENECKE • FC 17-05 • Significant reduction of cervical cancer incidence within a primary HPV screening pilot project in Wolfsburg, Germany (WOLPHSCREEN) See abstract > A. Alexander LUYTEN • FC 17-06 • Effectiveness of screening in HPV vaccinated women See abstract > K. K. LOUVANTO • FC 17-07 • First results of the EU-TOPIA project: towards improved cervical cancer prevention in Europe See abstract > I. Inge DE KOK • FC 17-08 • HPV infection among elderly women- results from a population based cohort study See abstract > L. L. BERGENGREN • FC 17-09 • If persistent HPV infection causes disease, why are we not measuring it? See abstract > L. L. VAUGHAN • FC 17-10 • Long term screening performance of cytology, HPV 16/18 genotyping, and E6 oncoprotein in triaging women with positive high-risk HPV test in China See abstract > X-L. Xue-Lian Zhao • FC 17-11 • Comparative performance evaluation of screening tools for point of care cervical cancer screening and pre cancer treatment among women living with HIV: case for integrating cervical cancer screening with HIV testing and counseling centers in resource limited settings See abstract > S. S. PIMPLE • FC 17-12 • A new technique of DNA isothermal amplification techniques in cervical cancer screening See abstract > L. L. WANG